Our Company

BELLUS Health is a development-focused health company concentrating on the development of products that provide innovative health solutions and address critical unmet medical needs. Our vision focuses on the most important and value-creating portion of the biotech product life cycle: the one which goes from the pre-clinical stage to phase II proof-of-concept studies.

BELLUS Health’s product strategy targets both pharmaceuticals and nutraceuticals. The Company’s pharmaceuticals portfolio of products includes investigational product candidates for the treatment of AA amyloidosis and Alzheimer’s disease. With respect to nutraceuticals, the Company developed VIVIMIND™ (homotaurine), a patented, science-based natural health product shown to protect memory function.

BELLUS Health's head office is situated in the Parc scientifique et de haute technologie de Laval, in Laval, Quebec, Canada.

Pipeline Overview

BELLUS Health's pipeline contains promising therapeutic products at various stages of development aimed at providing innovative health solutions that address critical unmet medical needs and which have the potential to be large growth drivers.